Akershus universitetssykehus HF er et universitetssykehus i Norge, som ligger i Lørenskog i Akershus, like øst for Oslo. Sykehuset har rundt 9 000 ansatte og en kapasitet på nærmere 1 000 senger. Det er ett av to universitetssykehus tilknyttet Universitetet i Oslo, ved siden av Oslo universitetssykehus.

During the past decade, Akershus University Hospital conducted 100 clinical trials. In the 10-year time frame, 100 clinical trials started and 5 clinical trials were completed, i.e. on average, 5% percent of trials that started reached the finish line to date. In the past 5 years, 54 clinical trials started and 3 clinical trials were completed. i.e. 5.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Akershus University Hospital" #1 sponsor was "University Hospital, Akershus" with 53 trials, followed by "Oslo University Hospital" with 14 trials sponsored, "Haukeland University Hospital" with 10 trials sponsored, "University of Oslo" with 6 trials sponsored and "Incyte Corporation" with 6 trials sponsored. Other sponsors include 54 different institutions and companies that sponsored additional 50 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Akershus University Hospital" #1 collaborator was "University Hospital, Akershus" with 33 trials as a collaborator, "Oslo University Hospital" with 25 trials as a collaborator, "Haukeland University Hospital" with 21 trials as a collaborator, "Helse Stavanger HF" with 15 trials as a collaborator and "St. Olavs Hospital" with 14 trials as a collaborator. Other collaborators include 250 different institutions and companies that were collaborators in the rest 144 trials.

According to Clinical.Site data, the most researched conditions in "Akershus University Hospital" are "Crohn Disease" (7 trials), "Breast Cancer" (4 trials), "Heart Failure" (4 trials), "Multiple Sclerosis" (4 trials) and "Pulmonary Embolism" (3 trials). Many other conditions were trialed in "Akershus University Hospital" in a lesser frequency.

Most popular intervention types in "Akershus University Hospital" are "Drug" (57 trials), "Other" (31 trials), "Procedure" (24 trials), "Behavioral" (7 trials) and "Biological" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Ozanimod" (3 trials), "placebo" (3 trials), "Abelacimab" (2 trials) and "Control" (2 trials). Other intervention names were less common.

The vast majority of trials in "Akershus University Hospital" are 131 trials for "All" genders, 12 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Akershus University Hospital". undefined are not yet recruiting, 51 are recruiting, 21 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 53 completed trials in Akershus University Hospital, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Akershus University Hospital, 2 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 33 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 14 trials, and there were also 42 trials that are defined as “Not Applicable".